.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
McKinsey
McKesson
Federal Trade Commission
Queensland Health
Farmers Insurance
Express Scripts
Dow
Accenture
Fish and Richardson

Generic companies with the most tentative approvals

This chart shows the pharmaceutical companies with the most tentative generic drug approvals in 2016

The Food and Drug Administration (FDA) grants tentative approvals to generic entrants when their generic drug is approvable, but for the existence of unexpired patents on the branded drug. Because the FDA does not disclose the identify of Paragraph IV challengers, tentative approvals can be used to identify potential Paragraph IV filers — the patent challengers will likely have tentative approvals enabling them to rapidly launch their generic versions.

The companies with the most tentative approvals are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

botpot